Not yet recruiting
Axial spondyloarthritis+1
Not yet recruitingStudy to evaluate the effect of upadacitinib on the frequency of eye inflammation in patients with axial spondyloarthritis.
Registered drugNo placebo
Study to evaluate the effect of upadacitinib on the frequency of eye inflammation in patients with axial spondyloarthritis.
Registered drugNo placebo
- Disease:Axial spondyloarthritisIridocyclitis
- Substances:Upadacitinib
Countries:
Bulgaria
Bulgaria- Participants:18–64 years · 65+ years
- Substances:Upadacitinib
- Sponsor:Care Arthritis Ltd.
